IT 901
CAS: 1584121-99-2
Ref. 3D-JNC12199
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Información del producto
IT 901 is a combination strategy that targets the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). It is an orally administered drug that has been shown to be effective in cancer treatment. This drug has been shown to target chronic lymphocytic leukemia cells and leukemia cells, which are activated due to constitutive activation of NF-κB. IT901 also inhibits proliferation of leukemia cells by modulating the microenvironment, which may be due to its ability to induce apoptosis.
Propiedades químicas
Consulta técnica sobre: 3D-JNC12199 IT 901
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
